Connect your AI

TriSalus Life Sciences, Inc. TLSI Price / sales

Price / sales at other companies

Boston ScientificBSX

4.5×-4.0×

AngioDynamicsANGO

1.5×+0.2×

Delcath SystemsDCTH

3.6×-4.3×

Tactile Systems TechnologyTCMD

1.7×+0.7×

LQD

Liquidia CorporationLQDA

11.5×-77.4×

United TherapeuticsUTHR

8.2×+3.6×

Other financials

Income statement

Revenue$8.9M-2.9%

Gross profit$7.7M0.0%

Operating income-$8.4M-14.8%

Net income$1.5M+115%

EPS (diluted)$0.03+108%

Balance sheet

Cash & equivalents$56.6M+324%

Total debt$33.1M+4.4%

Total equity$12.8M+137%

Total assets$71.0M+148%

Cash flow

Operating cash flow-$6.5M-44.0%

CapEx$141.0K-81.3%

Free cash flow-$6.6M-26.0%

Valuation

Market cap$279.45M+49.6%

Enterprise value$255.97M+33.6%

Profitability

Gross margin85.1%-0.5pp

Operating margin-62.4%-16.8pp

Net margin-60.9%-13.4pp

FCF margin-45.2%-16.8pp

Returns & leverage

Return on equity253.3%—

Debt / equity2.6×—

Current ratio5.8×+3.6×

Where this comes from

Calculated from TriSalus Life Sciences, Inc.’s reported figures.

market cap/total revenue=5.5×

Based on the most recent quarter.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is TriSalus Life Sciences, Inc.'s price / sales?: TriSalus Life Sciences, Inc. (TLSI) reported price / sales of 5.5× in Q1 2026.
How has TriSalus Life Sciences, Inc.'s price / sales changed year-over-year?: TriSalus Life Sciences, Inc.'s price / sales increased by 1.7% year-over-year, from 5.4× to 5.5×.
What is the long-term trend for TriSalus Life Sciences, Inc.'s price / sales?: Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s price / sales has grown at a 34.2% compound annual growth rate (CAGR), from 4.3× to 7.7×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.